Aileron Therapeutics, Inc. (ALRN): Price and Financial Metrics

Aileron Therapeutics, Inc. (ALRN): $2.11

0.18 (+9.33%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

F

Add ALRN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#256 of 338

in industry

ALRN Price/Volume Stats

Current price $2.11 52-week high $7.42
Prev. close $1.93 52-week low $1.61
Day low $1.96 Volume 63,300
Day high $2.17 Avg. volume 64,833
50-day MA $2.70 Dividend yield N/A
200-day MA $3.28 Market Cap 45.72M

ALRN Stock Price Chart Interactive Chart >


Aileron Therapeutics, Inc. (ALRN) Company Bio


Aileron Therapeutics is a clinical-stage biopharmaceutical company advancing a novel class of therapeutics called stapled peptides, which represent the first general solution, or "scaffold" for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell. The company's lead product candidate ALRN-6924 is being evaluated in multiple clinical trials. The company was founded in 2005 and is based in Cambridge, Massachusetts.


ALRN Latest News Stream


Event/Time News Detail
Loading, please wait...

ALRN Latest Social Stream


Loading social stream, please wait...

View Full ALRN Social Stream

ALRN Price Returns

1-mo 0.00%
3-mo -44.91%
6-mo 14.05%
1-year -56.04%
3-year -75.29%
5-year -84.80%
YTD -8.26%
2024 -24.56%
2023 28.63%
2022 -78.95%
2021 -45.88%
2020 81.50%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!